Skip to main content
TipRanks
Go Ultimate75% OFF

XPRO India Limited (XPROINDIA) AI Stock Analysis

0 Followers
IN:XPROINDIA

XPRO India Limited

(NSE:XPROINDIA)

Select Model
Rating:54Neutral
Price Target:INR 1,125.00â–¼(-5.55% Downside)
Action:reiterated
Date:11/05/26

The score is primarily constrained by deteriorating earnings and weak cash conversion, despite a stronger balance sheet. Mixed technical signals and an expensive valuation further limit the investment profile.

Positive Factors
Growing Equity BaseThe substantial increase in equity provides a larger capital cushion and supports the company’s ability to sustain its asset base. Over the next several quarters, this stronger foundation can improve resilience and preserve capacity to fund operations or selected growth initiatives.
Negative Factors
Recent Earnings DeteriorationThe latest decline in revenue and sharp reduction in net income weaken the near-term earnings base and raise questions about operating resilience. If this trajectory persists, reduced profitability could limit internal reinvestment, weaken returns, and constrain the company’s ability to absorb business pressures.

XPRO India Limited (XPROINDIA) vs. iShares MSCI India ETF (INDA)

-30%-20%-10%0%10%20%30%40%50%IN:XPROINDIA+16.73%INDA-5.59%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 28.09B
Dividend Yield
0.17%
Average Volume (3M)
6,629
Price to Earnings (P/E)
79.0
Beta (1Y)
1.19
Revenue Growth
12.17%
EPS Growth
151.13%
Country
India
Employees
658
Sector
General
Sector Strength
55
Industry
Chemicals - Specialty

XPRO India Limited Business Overview & Revenue Model

Company Description

Xpro India Limited processes and sells polymers primarily in India. The company offers dielectric films for applications comprising power transmission and distribution, motor run, power film/electronic, magnetic lighting ballast, microwave oven, low...

XPRO India Limited Financial Statement Overview

Summary

Financial performance is mixed: the balance sheet is comparatively strong with expanding equity and moderate leverage, but recent earnings have weakened and cash generation is poor, with deeply negative free cash flow.

Income Statement

58Neutral

Balance Sheet

74Positive

Cash Flow

45Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue5.92B5.05B5.35B4.65B5.11B4.72B
Gross Profit1.20B1.05B1.08B1.48B1.61B1.22B
EBITDA734.50M474.16M691.21M763.08M769.51M647.19M
Net Income352.39M192.34M379.97M438.79M453.64M449.32M
Balance Sheet
Total Assets12.41B12.18B9.93B6.77B3.40B3.35B
Cash, Cash Equivalents and Short-Term Investments2.33B2.99B2.61B2.05B264.11M193.63M
Total Debt3.16B3.25B2.69B390.00M386.82M898.87M
Total Liabilities4.28B4.20B3.82B1.17B1.07B1.63B
Stockholders Equity7.75B7.60B6.10B5.61B2.34B1.72B
Cash Flow
Free Cash Flow0-1.14B-2.62B58.15M465.36M420.77M
Operating Cash Flow0270.46M252.35M439.79M828.55M486.21M
Investing Cash Flow0-1.75B-1.31B-3.20B-582.75M-104.59M
Financing Cash Flow01.58B2.08B2.78B-431.40M-211.58M

XPRO India Limited Technical Analysis

Technical Analysis SentimentPositive
Last Price1191.15

Price Trends

50DMA1135.22Positive
100DMA1210.27Negative
200DMA1122.65Positive

Market Momentum

MACD17.22Negative
RSI64.57Neutral
STOCH94.48Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:XPROINDIA, the sentiment is Positive. The current price of 1191.15 is above the 20-day moving average (MA) of 1051.11, above the 50-day MA of 1135.22, and above the 200-day MA of 1122.65, indicating a bullish trend. The MACD of 17.22 indicates Negative momentum. The RSI at 64.57 is Neutral, neither overbought nor oversold. The STOCH value of 94.48 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:XPROINDIA.

XPRO India Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:XPROINDIA against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:FCLIN:FCL69NeutralINR 57.51B41.21―0.26%91.44%19.67%
IN:NOCILIN:NOCIL67NeutralINR 22.97B29.39―1.09%12.29%23.76%
IN:ROSSARIIN:ROSSARI65NeutralINR 23.61B15.49―0.12%19.76%11.74%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:TATVAIN:TATVA55NeutralINR 38.76B61.74―0.12%49.69%254.75%
IN:XPROINDIAIN:XPROINDIA54NeutralINR 27.96B78.97―0.17%12.17%151.13%
IN:NEOGENIN:NEOGEN50NeutralINR 80.34B178.99―0.04%26.66%51.16%

* General Sector Average

Performance Comparison

0%50%100%IN:XPROINDIAIN:FCLIN:NEOGENIN:NOCILIN:ROSSARIIN:TATVADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:XPROINDIA and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:XPROINDIAXPRO India Limited1191.15167.4616.36%
IN:FCLFineotex Chemical Limited49.3924.6799.77%
IN:NEOGENNeogen Chemicals Ltd.2674.101369.98105.05%
IN:NOCILNOCIL Limited137.55-32.61-19.17%
IN:ROSSARIRossari Biotech Ltd426.25-198.45-31.77%
IN:TATVATatva Chintan Pharma Chem Limited1656.95101.176.50%

XPRO India Limited Corporate Events

Xpro India Board Approves Results, Guarantee and Leadership Changes

Nov 3, 2026

Xpro India Limited’s board approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. It also approved a corporate guarantee of up to AED 83 million, approximately INR 215 crore, in favour...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 05, 2026